Arrow Electronics (ARW) reported Q4 2025 earnings Feb 5. Non-GAAP EPS $4.39 (vs $3.56 est, +23% beat), revenue $8.7B (+20% YoY), Q1 guidance $7.95-8.55B revenue and $2.70-2.90 EPS (well above street). Fourth consecutive quarterly beat.

Stock at $141, forward P/E 9.96x. Analyst consensus: mean target $113 (-20% from current), 50% bearish ratings, Wells Fargo Underweight at $94, BofA Underperform at $110. The sell-side is modeling a different company.

Cross-ticker supply chain convergence confirms cycle turn:

Nine independent signals across the electronics supply chain point the same direction:

• ARW (Feb 5): Book-to-bill above parity all 3 regions, backlog up 4 consecutive quarters, lead times modestly expanding
• AVT (Jan 28): Book-to-bill positive all regions, lead times "trending higher across most product categories," spot pricing up on memory/storage/controllers/capacitors
• SXI (Jan 30): Record order book, book-to-bill 1.08 in electronics (6th consecutive quarter ≥1)
• KLIC: General semi revenue +90% YoY, ball bonding utilization >80%
• SNDK/MU/WDC (Jan 29): NAND pricing +40-100% Q/Q, demand outpacing supply, transitioning to multi-year supply agreements
• STX: Nearline fully allocated through CY2026, booking into 2027
• COHR: Data center book-to-bill >4x, CY2026 booked out
• UMC: Leading-edge foundries deprioritizing mature nodes → tighter supply
• LRCX (Jan 28): NAND growing faster than expected

This is the exact pattern from the SNDK example (evidence ev-e3eu26): "cross-transcript supply chain signals predicted magnitude of beat." When distributors, memory, foundry, equipment, and passives all report tightening at once, the cycle has turned.

Secondary thesis - structural re-rating potential:

The cyclical turn is PRIMARY. But there's a longer-duration structural story that could support multiple expansion if it validates over coming quarters:

1. Value-added services shift: Management called them "margin accretive" in 4 consecutive quarters (Q1-Q4 2025) and highlighted their growing contribution to operating leverage
2. ECS platform evolution: Recurring revenue now 1/3 of ECS billings, backlog up over 75% YoY to all-time high
3. New go-to-market model: Arrow becomes exclusive commercial partner for suppliers, selling licenses/subscriptions on their behalf — management says "meaningfully margin accretive once at scale"
4. Microsoft validation: Named Arrow 2025 Distributor Partner of the Year for ArrowSphere AI

The sell-side is modeling ARW as a low-margin box-mover in cyclical recovery. If the ECS platform thesis (ArrowSphere, exclusive partnerships, recurring revenue) and value-added services mix shift are real, the multiple should re-rate higher. Forward P/E ≈10x on what appears to be early-cycle earnings with improving quality.

Entry timing is the issue:

Stock +26.5% in one month, RSI 80, at 99% of 52-week range. Technically overbought after massive run. Same pattern at AVT (+31% 1M, RSI 84). The immediate alpha window on the cyclical trade is compressed.

Investment implication:

The cross-ticker convergence (cyclical turn) is high-conviction and well-documented across 9 independent sources. The structural re-rating thesis (ECS platform, recurring revenue) is longer-duration and needs validation in coming quarters. But both ARW and AVT have already moved substantially.

This is a watchlist position for pullback entry or for validation as analyst upgrades trickle in. The cyclical convergence is real — timing is the constraint. Don't chase the move — wait for entry.

Negatives:

CEO vacancy ongoing 5+ months (strategy uncertainty, though execution is strong under interim leadership). Regional mix headwinds (Asia growing faster than higher-margin Western regions).